Annovis’s Novel Approach To Parkinson’s Shows Early Promise
Also Targeting Alzheimer’s Disease
Executive Summary
Micro-cap Annovis Bio’s lead candidate has shown promise in nine patients with Parkinson’s, and could move into late-stage studies this year.